• Home
  • News
  • Coins2Day 500
  • Tech
  • Finance
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
HealthCOVID-19 vaccines

FDA authorizes Pfizer and Moderna COVID vaccines for children under 5

By
Fiona Rutherford
Fiona Rutherford
and
Bloomberg
Bloomberg
Down Arrow Button Icon
By
Fiona Rutherford
Fiona Rutherford
and
Bloomberg
Bloomberg
Down Arrow Button Icon
June 17, 2022, 9:30 AM ET

COVID vaccines for children ages 5 and under from Pfizer Inc. And Moderna Inc. Received authorization from U.S. Regulators, meaning almost all of the American population can soon get protected against COVID-19 disease. 

The Food and Drug Administration clearance allows the use of Pfizer’s three-dose vaccine for youngsters ages six months through 4 years, made with German partner BioNTech SE, and Moderna’s two-dose vaccine for children six months through 5 years, according to a statement from the agency. The FDA also cleared the use of Moderna’s COVID shot for children and adolescents 6 to 17 years old. Until now, only Pfizer’s vaccine was available for this age group.

It’s been a year and a half since vaccines first became available, and an authorized vaccine will be welcome news for parents whose youngsters haven’t been able to get their shots. Pfizer’s vaccine had been delayed earlier when a two-dose regimen didn’t evoke an adequate response. 

The vaccines for the youngest of kids are expected to be rolled out as early as June 21, the Biden administration said earlier this month. The U.S. Government has already secured a supply of 10 million doses from Pfizer and Moderna to vaccinate under-5s as soon as the FDA and the Centers for Disease Control and Prevention give the green light. 

Government programs and medical groups will provide education around vaccination’s risks and benefits. Once fully cleared by FDA and recommended by CDC, the shots will become available through a variety of locations, including pediatrician’s offices, and information will be available at the vaccines.gov website. 

While children are less likely than adults to experience the worst outcomes of COVID, the health officials have warned that the rate of hospitalization and death for children, particularly during the Omicron wave, has been concerning.

“Certainly our elder community has been among those that have been highest to cause risk of severe disease and death, but I will also say that COVID is one of the top leading killers of children right now,” CDC Director Rochelle Walensky said during a Senate Health, Education, Labor, and Pensions committee hearing on Thursday. Deaths from Covid among children, Walensky added, “have been higher than what we’ve seen for flu.”

Advisers to the CDC will hold are holding a meeting Friday and Saturday to discuss the shots for kids. The panel of outside experts, the Advisory Committee on Immunization Practices, advises the CDC on how best to administer new vaccines. Walensky will need to sign off on any recommendations before vaccines can begin to be administered.

Sign up for the Coins2Day Features email list so you don’t miss our biggest features, exclusive interviews, and investigations.

About the Authors
By Fiona Rutherford
See full bioRight Arrow Button Icon
By Bloomberg
See full bioRight Arrow Button Icon
Rankings
  • 100 Best Companies
  • Coins2Day 500
  • Global 500
  • Coins2Day 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Coins2Day Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Coins2Day Brand Studio
  • Coins2Day Analytics
  • Coins2Day Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Coins2Day
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Coins2Day Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Coins2Day Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.